| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.94B | +0.6% |
| Cost of Revenue | $770.3M | -5.1% |
| Gross Profit | $1.05B | +6.8% |
| R&D Expense | $283.3M | +1.4% |
| SG&A Expense | $168.9M | -4.1% |
| Operating Income | $202.8M | +33.9% |
| Pre-tax Income | $203.6M | +31.8% |
| Income Tax | $54.2M | +36.2% |
| Net Income | $144.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $342.0M | +17.7% |
| Short-term Investments | $23.2M | -11.4% |
| Accounts Receivable | $582.1M | -27.3% |
| Current Assets | $1.07B | -12.4% |
| Total Assets | $2.20B | -2.9% |
| Current Liabilities | $844.7M | -19.3% |
| Total Liabilities | $1.02B | -14.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $311.2M | +20.6% |
| Investing Cash Flow | -$101.1M | -3.3% |
| Financing Cash Flow | -$151.5M | +44.0% |
| +29.6% |
| EPS (Basic) | $2.73 | +33.8% |
| EPS (Diluted) | $2.64 | +38.9% |
| Stockholders' Equity |
| $1.15B |
| +9.5% |